702. Hepatic Safety Among Patients Treated with Anti-Fungal Triazole Agent Posaconazole: Characterization of Adverse events in a Manufacturer’s Safety Database
Gespeichert in:
Veröffentlicht in: | Open forum infectious diseases 2019-10, Vol.6 (Supplement_2), p.S317-S317 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | S317 |
---|---|
container_issue | Supplement_2 |
container_start_page | S317 |
container_title | Open forum infectious diseases |
container_volume | 6 |
creator | Zhou, Yun-Ping O’Flynn, Rose Waskin, Hetty Leong, Ronald W Straus, Walter |
description | |
doi_str_mv | 10.1093/ofid/ofz360.770 |
format | Article |
fullrecord | <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6810868</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_6810868</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1360-374f842842aa0c2259bb1658a2174226fc11683123c458b24d5adf879f5bd0be3</originalsourceid><addsrcrecordid>eNpVkc1KAzEQx4MoKNWz17zAtkn2K-tBWKq1QkVBPYfZbNJG2qQk20p78jU8-mo-idGqKAwzw3z8mOGP0CklfUqqdOC0aaPbpgXplyXZQ0csZTzhVV7u_8kP0UkIT4QQSklOyuoIvZWE9fFYLaEzEt-DVt0G1wtnp_gulpTtAn7wCjrV4mfTzXBtO5OMVnYK89gwsHVzhetpHMR3LoB09qt0hocz8CA75c02gpzFTuO6XSsfFFbrL7CxGPAN2JWOgyuv_PvLa_g54gI6aCCoY3SgYR7UyXfsocfR5cNwnExur66H9SSRNH6dpGWmecaiARDJWF41DS1yDoyWGWOFlpQWPKUslVnOG5a1ObSal5XOm5Y0Ku2h8x13uWoWqpXxQg9zsfRmAX4jHBjxv2PNTEzdWhScEh7RPTTYAaR3IXilf3cpEZ8qiU-VxE4lEVVKPwAK_ItG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>702. Hepatic Safety Among Patients Treated with Anti-Fungal Triazole Agent Posaconazole: Characterization of Adverse events in a Manufacturer’s Safety Database</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford Journals Open Access Collection</source><source>PubMed Central</source><creator>Zhou, Yun-Ping ; O’Flynn, Rose ; Waskin, Hetty ; Leong, Ronald W ; Straus, Walter</creator><creatorcontrib>Zhou, Yun-Ping ; O’Flynn, Rose ; Waskin, Hetty ; Leong, Ronald W ; Straus, Walter</creatorcontrib><identifier>ISSN: 2328-8957</identifier><identifier>EISSN: 2328-8957</identifier><identifier>DOI: 10.1093/ofid/ofz360.770</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Abstracts</subject><ispartof>Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S317-S317</ispartof><rights>The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810868/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810868/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53770,53772</link.rule.ids></links><search><creatorcontrib>Zhou, Yun-Ping</creatorcontrib><creatorcontrib>O’Flynn, Rose</creatorcontrib><creatorcontrib>Waskin, Hetty</creatorcontrib><creatorcontrib>Leong, Ronald W</creatorcontrib><creatorcontrib>Straus, Walter</creatorcontrib><title>702. Hepatic Safety Among Patients Treated with Anti-Fungal Triazole Agent Posaconazole: Characterization of Adverse events in a Manufacturer’s Safety Database</title><title>Open forum infectious diseases</title><subject>Abstracts</subject><issn>2328-8957</issn><issn>2328-8957</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpVkc1KAzEQx4MoKNWz17zAtkn2K-tBWKq1QkVBPYfZbNJG2qQk20p78jU8-mo-idGqKAwzw3z8mOGP0CklfUqqdOC0aaPbpgXplyXZQ0csZTzhVV7u_8kP0UkIT4QQSklOyuoIvZWE9fFYLaEzEt-DVt0G1wtnp_gulpTtAn7wCjrV4mfTzXBtO5OMVnYK89gwsHVzhetpHMR3LoB09qt0hocz8CA75c02gpzFTuO6XSsfFFbrL7CxGPAN2JWOgyuv_PvLa_g54gI6aCCoY3SgYR7UyXfsocfR5cNwnExur66H9SSRNH6dpGWmecaiARDJWF41DS1yDoyWGWOFlpQWPKUslVnOG5a1ObSal5XOm5Y0Ku2h8x13uWoWqpXxQg9zsfRmAX4jHBjxv2PNTEzdWhScEh7RPTTYAaR3IXilf3cpEZ8qiU-VxE4lEVVKPwAK_ItG</recordid><startdate>20191023</startdate><enddate>20191023</enddate><creator>Zhou, Yun-Ping</creator><creator>O’Flynn, Rose</creator><creator>Waskin, Hetty</creator><creator>Leong, Ronald W</creator><creator>Straus, Walter</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20191023</creationdate><title>702. Hepatic Safety Among Patients Treated with Anti-Fungal Triazole Agent Posaconazole: Characterization of Adverse events in a Manufacturer’s Safety Database</title><author>Zhou, Yun-Ping ; O’Flynn, Rose ; Waskin, Hetty ; Leong, Ronald W ; Straus, Walter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1360-374f842842aa0c2259bb1658a2174226fc11683123c458b24d5adf879f5bd0be3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Abstracts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhou, Yun-Ping</creatorcontrib><creatorcontrib>O’Flynn, Rose</creatorcontrib><creatorcontrib>Waskin, Hetty</creatorcontrib><creatorcontrib>Leong, Ronald W</creatorcontrib><creatorcontrib>Straus, Walter</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Open forum infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhou, Yun-Ping</au><au>O’Flynn, Rose</au><au>Waskin, Hetty</au><au>Leong, Ronald W</au><au>Straus, Walter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>702. Hepatic Safety Among Patients Treated with Anti-Fungal Triazole Agent Posaconazole: Characterization of Adverse events in a Manufacturer’s Safety Database</atitle><jtitle>Open forum infectious diseases</jtitle><date>2019-10-23</date><risdate>2019</risdate><volume>6</volume><issue>Supplement_2</issue><spage>S317</spage><epage>S317</epage><pages>S317-S317</pages><issn>2328-8957</issn><eissn>2328-8957</eissn><cop>US</cop><pub>Oxford University Press</pub><doi>10.1093/ofid/ofz360.770</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2328-8957 |
ispartof | Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S317-S317 |
issn | 2328-8957 2328-8957 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6810868 |
source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford Journals Open Access Collection; PubMed Central |
subjects | Abstracts |
title | 702. Hepatic Safety Among Patients Treated with Anti-Fungal Triazole Agent Posaconazole: Characterization of Adverse events in a Manufacturer’s Safety Database |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T18%3A26%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=702.%20Hepatic%20Safety%20Among%20Patients%20Treated%20with%20Anti-Fungal%20Triazole%20Agent%20Posaconazole:%20Characterization%20of%20Adverse%20events%20in%20a%20Manufacturer%E2%80%99s%20Safety%20Database&rft.jtitle=Open%20forum%20infectious%20diseases&rft.au=Zhou,%20Yun-Ping&rft.date=2019-10-23&rft.volume=6&rft.issue=Supplement_2&rft.spage=S317&rft.epage=S317&rft.pages=S317-S317&rft.issn=2328-8957&rft.eissn=2328-8957&rft_id=info:doi/10.1093/ofid/ofz360.770&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_6810868%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |